Le Lézard
Classified in: Health
Subjects: MAV, NTA, FVT, CFG, MAT

Notice to Media - Minister of Health to visit the Greater Toronto Area


TORONTO, June 23, 2019 /CNW/ - The Honourable Ginette Petitpas Taylor, federal Minister of Health, will visit Toronto and Brampton to deliver health-related announcements.

Date

Monday, June 24, 2019

10:00 a.m. (EDT): Minister Petitpas Taylor will announce funding for community-based cannabis public education and awareness initiatives.

Location
Dovercourt Boys and Girls Club
180 Westmoreland Ave
Toronto, ON

Note for Media:
There will be a media availability immediately following the announcement.

12:15 p.m. (EDT): Minister Petitpas Taylor will deliver remarks at the Empire Club of Canada on the topic "From hospital to home: Preparing our health care system for an aging Canada."

Location
Arcadian Court
401 Bay Street
Simpson Tower, 8th Floor
Toronto, ON

2:30 p.m. (EDT): Minister Petitpas Taylor will announce the availability of Canada's Food Guide in Indigenous and multicultural languages.

Location
Chalo! FreshCo
8405 Financial Drive
Brampton, ON

Note for Media:
There will be a media availability immediately following the announcement.

Tuesday, June 25, 2019

10:00 a.m. (EDT): The Honourable Ginette Petitpas Taylor, federal Minister of Health, will announce Government of Canada funding that will benefit Canadians at risk of developing type 2 diabetes.

Location
Main Lobby
LMC Brampton
2979 Bovaird Drive East
Brampton, ON

Note for Media:
There will be a media availability immediately following the announcement.

 

SOURCE Health Canada


These press releases may also interest you

at 00:05
ImmunityBio Announces Positive Overall Survival Results of Anktiva Combined With Checkpoint Inhibitors in Non-Small Cell Lung Cancer; Meeting Scheduled with FDA to Discuss Registration Path for ANKTIVA in Lung Cancer
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
Few small SUVs excel in new IIHS front crash prevention test
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential expands globally to Oceania, Asia and the Gulf
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research Statement on Co-Founder and Chairman Dr. Stephen Harrison
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

More news about Health...


News published on and distributed by: